Assessment of Quality Indicators for Appropriate Antibiotic Use

被引:13
作者
Arcenillas, Paula [1 ]
Boix-Palop, Lucia [2 ,5 ]
Gomez, Lucia [2 ]
Xercavins, Mariona [3 ]
March, Pablo [1 ,6 ]
Martinez, Laura [1 ]
Riera, Montserrat [4 ]
Madridejos, Rosa [6 ]
Badia, Cristina [4 ]
Nicolas, Jordi [1 ,7 ]
Calbo, Esther [2 ,5 ]
机构
[1] Hosp Univ Mutua Terrassa, Pharm Dept, Barcelona, Spain
[2] Hosp Univ Mutua Terrassa, Dept Internal Med, Infect Dis Unit, Barcelona, Spain
[3] CATLAB, Microbiol Dept, Barcelona, Spain
[4] Hosp Univ Mutua Terrassa, Infect Control & Antimicrobial Stewardship, Barcelona, Spain
[5] Univ Int Catalunya, Barcelona, Spain
[6] Mutua Terrassa, Pharm Dept, Primary Care Pharm, Barcelona, Spain
[7] Univ Barcelona, Barcelona, Spain
关键词
antibiotic stewardship; antimicrobial resistance; quality indicators; COMMUNITY-ACQUIRED PNEUMONIA; URINARY-TRACT-INFECTIONS; ANTIMICROBIAL STEWARDSHIP; REDUCES LENGTH; IMPACT; GUIDELINES; THERAPY; PROGRAM; IMPROVE;
D O I
10.1128/AAC.00875-18
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
One of the critical elements of antimicrobial stewardship programs is the ability to measure the quality of antibiotic prescriptions. The aims of the present study were to evaluate the performance properties of a set of previously developed quality indicators (QIs) and to identify the potential room for improvement in antibiotic use in our setting. A monthly cross-sectional point prevalence survey was conducted in a 400-bed acute care teaching hospital, from June to November 2015. All adult patients treated for >= 24 hours with antibiotic therapy for a suspected hospitalor community-acquired bacterial infection were included. Performance scores (adherence, room for improvement, interobserver reliability, and applicability) were calculated for 8 QIs. A total of 362 patients were evaluated. Adherence to the whole set of QIs was accomplished for 14.1% of evaluable patients. The QIs with greater room for improvement were adequate request for blood cultures (60.6%), therapeutic drug monitoring (TDM) (59.1%), sequential antibiotic therapy within 72 hours (48.2%), and empirical antibiotic therapy according to local guidelines (30.4%). The percentage of patients receiving unnecessary antibiotic treatment in the absence of clinical or microbiological evidence of infection after 5 days was 12.2%. All indicators scored kappa values of >= 0.6, suggesting good interobserver reliability. Low applicability (6.1% of reviewed patients) was found only for the TDM QI. The QIs analyzed were found to be applicable, showed good interobserver reliability, and were useful tools to identify areas with potential room for improvement in antibiotic use.
引用
收藏
页数:9
相关论文
共 31 条
  • [1] [Anonymous], 2014, Antimicrobial resistance: global report on surveillance
  • [2] Impact of guideline-concordant antibiotics and macrolide/-lactam combinations in 3203 patients hospitalized with pneumonia: prospective cohort study
    Asadi, L.
    Eurich, D. T.
    Gamble, J. M.
    Minhas-Sandhu, J. K.
    Marrie, T. J.
    Majumdar, S. R.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (03) : 257 - 264
  • [3] Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre
    Cisneros, J. M.
    Neth, O.
    Gil-Navarro, M. V.
    Lepe, J. A.
    Jimenez-Parrilla, F.
    Cordero, E.
    Rodriguez-Hernandez, M. J.
    Amaya-Villar, R.
    Cano, J.
    Gutierrez-Pizarraya, A.
    Garcia-Cabrera, E.
    Molina, J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (01) : 82 - 88
  • [4] European Surveillance of antimicrobial consumption (ESAC): quality indicators for outpatient antibiotic use in Europe
    Coenen, Samuel
    Ferech, Matus
    Haaijer-Ruskamp, Flora M.
    Butler, Chris C.
    Stichele, Robert H. Vander
    Verheij, Theo J. M.
    Monnet, Dominique L.
    Goossens, Paul Little Herman
    [J]. QUALITY & SAFETY IN HEALTH CARE, 2007, 16 (06): : 440 - 445
  • [5] Davey P, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub4, 10.1002/14651858.CD003543.pub3]
  • [6] Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices
    Dellit, Timothy H.
    Chan, Jeannie D.
    Skerrett, Shawn J.
    Nathens, Avery B.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (06) : 525 - 533
  • [7] Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
    Dellit, Timothy H.
    Owens, Robert C.
    McGowan, John E., Jr.
    Gerding, Dale N.
    Weinstein, Robert A.
    Burke, John P.
    Huskins, W. Charles
    Paterson, David L.
    Fishman, Neil O.
    Carpenter, Christopher F.
    Brennan, P. J.
    Billeter, Marianne
    Hooton, Thomas M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) : 159 - 177
  • [8] European Centre for Disease Prevention and Control (European Medicines Agency), 2009, BACT CHALL TIM REACT
  • [9] Development of quality indicators to evaluate antibiotic treatment of patients with community-acquired pneumonia in Indonesia
    Farida, Helmia
    Rondags, Angelique
    Gasem, M. Hussein
    Leong, Katharina
    Adityana, A.
    van den Broek, Peterhans J.
    Keuter, Monique
    Natsch, Stephanie
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 (04) : 501 - 509
  • [10] The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
    Gilbert, David N.
    Guidos, Robert J.
    Boucher, Helen W.
    Talbot, George H.
    Spellberg, Brad
    Edwards, John E., Jr.
    Scheld, W. Michael
    Bradley, John S.
    Bartlett, John G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) : 1081 - 1083